Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its ...

Five top-selling drugs, in some cases, are costing Americans thousands in out of pocket expenses weekly and monthly. Here's ...

Merck's power purchase agreement (PPA) with SK Innovation E&S will supply 16 megawatts of renewable electricity to life ...

German diversified group Merck KGaA is preparing to put its pigments business up for sale to fund investments at its drugs ...

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s ...

Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

Donald Trump’s man in London reiterated the US president’s demands for the UK to pay pharmaceutical companies more money.

Swiss pharma giant Novartis has been on a deal spree ahead of several major patent expiries. In late October it agreed a $12 ...

Merck , known as MSD outside of the United States and Canada, announced today that the province of Quebec has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to their publicly funded ...

While investor enthusiasm often focuses on big tech, clinical-stage biotech Recursion Pharmaceuticals (NASDAQ: RXRX) is ...

Merck, known as MSD outside of the United States and Canada, announced that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences (Blackstone) for the ...

Merck also lowered revenue guidance for 2025. 10 stocks we like better than Merck › The stock for pharmaceutical giant Merck ...